Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, May 19, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Tags
Forxiga
Tag:
Forxiga
Latest Pharma-News
Forxiga approved in EU for treatment of symptomatic chronic heart failure
admin
-
February 7, 2023
0
Latest Pharma-News
Forxiga approved in China for the treatment of chronic kidney disease
admin
-
September 6, 2022
0
Latest Pharma-News
AZ’s Forxiga approved in Japan for treatment of chronic kidney disease
admin
-
August 26, 2021
0
Latest Pharma-News
AstraZeneca’s First SGLT2 inhibitor Forxiga approved in China for heart failure
admin
-
February 4, 2021
0
Latest Pharma-News
AstraZeneca’sForxiga approved in Japan for chronic heart failure
admin
-
December 1, 2020
0
Latest Pharma-News
Forxiga approved in the EU for heart failure
admin
-
November 5, 2020
0
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025